Investigating how a specific drug can promote the growth of new retinal neurons in adult mammals.
Evidence of neurogenesis in an adult mammalian retina initiated by an alpha7 nAChR agonist
This study is looking at how a special eye drop called PNU-282987 might help regenerate nerve cells in the eye for adults, which could lead to new treatments for retinal diseases that don’t have many options right now.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Western Michigan University NIH-funded |
| Lab location | 1 site (Kalamazoo, United States) |
| Project ID | NIH-10796217 on NIH RePORTER |
What this research studies
This research explores the potential for regenerating retinal neurons in adult mammals using a drug called PNU-282987, which activates a specific receptor in the eye. The study aims to understand how this drug can stimulate Müller glial cells to produce new neurons, a process that is typically limited in adult mammals. By applying the drug as eye drops, researchers will analyze the effects on different retinal cell populations using advanced flow cytometry techniques. This could lead to new treatments for retinal diseases that currently have limited options.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with retinal conditions or those interested in regenerative therapies for eye health.
Not a fit: Patients with non-retinal conditions or those who do not respond to receptor activation therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies for retinal diseases, potentially restoring vision in patients.
How similar studies have performed: Previous studies have shown promising results in similar approaches using Müller glia for neurogenesis in animal models, indicating potential for success in this research.
Where this research is happening
Kalamazoo, United States
- Western Michigan University — Kalamazoo, United States (Active)
Researchers
- Principal investigator: Linn, Cindy L — Western Michigan University
- Study coordinator: Linn, Cindy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.